FDA Import Refusal 1FX-4468665-8/10002/1 — CIPLA LIMITED
The FDA refused shipment 1FX-4468665-8/10002/1 from CIPLA LIMITED (India) on Sep 18, 2026. The refused product falls under Drugs and Biologics — AMLODIPINE BESYLATE (ANTI-HYPERTENSIVE, PART II). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Sep 18, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 62ODA14 AMLODIPINE BESYLATE (ANTI-HYPERTENSIVE, PART II)
- Charges
- 75